Regulatory Models for Biosimilars

14 September 2009 Philadelphia, PA Past Event

Location

Pennsylvania Convention Center
Philadelphia, PA

Agenda

1:30 p.m. – 3:00 p.m.

On Monday, September 14, 2009 Foley Partner David Rosen will participate in a panel presentation at the Regulatory Affairs and Professionals Society (RAPS) 2009 Annual Conference and Exhibition. The panel, “Regulatory Models for Biosimilars,” will brief participants on the progress of pending bills in Congress that may provide a statutory path for biosimilars as the 1984 Hatch-Waxman Act did for drugs. The European regulatory system's approach to generic biologics and techniques for proving bioequivalence with products that appear similar, but present significant variations in immunogenicity will be discussed.

The session leader is Joel Falk, Executive Vice President, The Weinberg Group and also participating on the panel is Sandra Dennis, deputy general counsel for healthcare, Biotechnology Industry Organization (BIO)

To view more details regarding this presentation, please visit the RAPS site

Insights

Podcast Episode 24: Steve Cade, Partner
01 December 2020
Foley Career Perspectives
U.S. Companies Must Prepare to Pay Higher Wages for Specialty Occupation Foreign Workers
30 November 2020
Labor & Employment Law Perspectives
A Shield for Employers: State COVID-19 Indemnity Laws
30 November 2020
Coronavirus Resource Center:Back to Business
Federal Circuit Clarifies The “Reasonably Pertintent” Analogous Art Standard
30 November 2020
PTAB Trial Insights
HCCA San Francisco Regional Conference
04 December 2020
Virtual Conference
Webinar: Massachusetts Paid Family and Medical Leave 2021
02 December 2020
Webinar
CTeL Digital Health Summit 2020
01-04 December 2020
Virtual Conference
Virtual CLE Week
Every Tuesday & Thursday from December 1 - 17 2020
Webinar

Regulatory Models for Biosimilars

Location

Pennsylvania Convention Center
Philadelphia, PA

Agenda

1:30 p.m. – 3:00 p.m.